Kinin-B2 receptor mediated neuroprotection after NMDA excitotoxicity is reversed in the presence of kinin-B1 receptor agonists

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Martins, Antonio H ^a,c   Alves, Janaina M ^b   Perez, Dinely ^c   Carrasco, Marimeé ^c   Torres Rivera, Wilmarie ^c   Eterović, Vesna A ^c   Ferchmin, Pedro A ^c   Ulrich, Henning ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSIDAD CENTRAL DEL CARIBE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KININ B1 RECEPTOR; KININ B2 RECEPTOR; KININ DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ, DES ARG(9); BRADYKININ, DES-ARG(9)-; CARBOXYPEPTIDASE; DRUG DERIVATIVE; N METHYLASPARTIC ACID; NEUROPROTECTIVE AGENT;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; EXCITOTOXICITY; HIPPOCAMPAL CA1 REGION; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; RAT; SIGNAL TRANSDUCTION; SYNAPSE; ANIMAL; BRAIN LEVEL; DRUG POTENTIATION; METABOLISM; PHYSIOLOGY;

ANIMALS; BRADYKININ; BRAIN CHEMISTRY; CA1 REGION, HIPPOCAMPAL; CARBOXYPEPTIDASES; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; RATS; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2;

EID: 84856801043     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030755     Document Type: Article

References (39)

1. Flynn RW, MacWalter RS, Doney AS, (2008) The cost of cerebral ischaemia. Neuropharmacology 55: 250-256.
2. Camacho A, Massieu L, (2006) Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Arch Med Res 37: 11-18.
3. Small DL, Poulter MO, Buchan AM, Morley P, (1997) Alteration in NMDA receptor subunit mRNA expression in vulnerable and resistant regions of in vitro ischemic rat hippocampal slices. Neurosci Lett 232: 87-90.
4. Olney JW, (1994) Neurotoxicity of NMDA receptor antagonists: an overview. Psychopharmacol Bull 30: 533-540.
5. Martel MA, Wyllie DJ, Hardingham GE, (2009) In developing hippocampal neurons, NR2B-containing N-methyl-D-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience 158: 334-343.
6. Xia CF, Yin H, Borlongan CV, Chao L, Chao J, (2004) Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension 43: 452-459.
7. Yin H, Chao L, Chao J, (2005) Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via AKT-glycogen synthase kinase-3 and AKT-Bad.14-3-3 signaling pathways. J Biol Chem 280: 8022-8030.
8. Chao J, Chao L, (2005) Kallikrein-kinin in stroke, cardiovascular and renal disease. Exp Physiol 90: 291-298.
9. Andersen P, Bliss TV, Skrede KK, (1971) Unit analysis of hippocampal polulation spikes. Exp Brain Res 13: 208-221.
10. Liu X, Kim CN, Yang J, Jemmerson R, Wang X, (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157.
11. Vlahos CJ, Matter WF, Hui KY, Brown RF, (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248.
12. Bellucci F, Cucchi P, Catalani C, Giuliani S, Meini S, et al. (2009) Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts. Br J Pharmacol 158: 1996-2004.
13. Pang L, Sawada T, Decker SJ, Saltiel AR, (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270: 13585-13588.
14. Ehrenfeld P, Conejeros I, Pavicic MF, Matus CE, Gonzalez CB, et al. (2011) Activation of kinin B1 receptor increases the release of metalloproteases-2 and-9 from both estrogen-sensitive and-insensitive breast cancer cells. Cancer Let 301: 106-118.
15. Hartley DM, Choi DW, (1989) Delayed rescue of N-methyl-D-aspartate receptor-mediated neuronal injury in cortical culture. J Pharmacol Exp Ther 250: 752-758.
16. Ferchmin PA, Pérez D, Biello M, (2000) Spermine is neuroprotective against anoxia and N-methyl-D-aspartate in hippocampal slices. Brain Res 859: 273-279.
17. Ferchmin PA, Perez D, Eterovic VA, de Vellis J, (2003) Nicotinic receptors differentially regulate N-methyl-D-aspartate damage in acute hippocampal slices. J Pharmacol Exp Ther 305: 1071-1078.
18. Ferchmin PA, Hao J, Perez D, Penzo M, Maldonado HM, et al. (2005) Tobacco cembranoids protect the function of acute hippocampal slices against NMDA by a mechanism mediated by alpha4beta2 nicotinic receptors. J Neurosci Res 82: 631-641.
19. Cruden NL, Newby DE, (2008) Therapeutic potential of icatibant (HOE-140, JE-049). Expert Opin Pharmacother 9: 2383-2390.
20. Kohno T, Wang H, Amaya F, Brenner GJ, Cheng JK, et al. (2008) Bradykinin enhances AMPA and NMDA receptor activity in spinal cord dorsal horn neurons by activating multiple kinases to produce pain hypersensitivity. J Neurosci 28: 4533-4540.
21. Martins AH, Resende RR, Majumder P, Faria M, Casarini DE, et al. (2005) Neuronal differentiation of P19 embryonal carcinoma cells modulates kinin B2 receptor gene expression and function. J Biol Chem 280: 19576-19586.
22. Martins AH, Alves JM, Trujillo CA, Schwindt TT, Barnabé GF, et al. (2008) Kinin-B2 receptor expression and activity during differentiation of embryonic rat neurospheres. Cytometry A 73: 361-368.
23. Trujillo CA, Schwindt TT, Martins AH, Alves JM, Mello LE, et al. (2009) Novel perspectives of neural stem cell differentiation: from neurotransmitters to therapeutics. Cytometry A 75: 38-53.
24. Miho Y, Kouroku Y, Fujita E, Mukasa T, Urase K, et al. (1999) bFGF inhibits the activation of caspase-3 and apoptosis of P19 embryonal carcinoma cells during neuronal differentiation. Cell Death Differ 6: 463-470.
25. Christiansen SC, Eddleston J, Woessner KM, Chambers SS, Ye R, Pan ZK, Zuraw BL, (2002) Up-regulation of functional kinin B1 receptors in allergic airway inflammation. J Immunol 169: 2054-60.
26. Danielisová V, Gottlieb M, Némethová M, Burda J, (2008) Effects of bradykinin postconditioning on endogenous antioxidant enzyme activity after transient forebrain ischemia in rat. Neurochem Res 33: 1057-1064.
27. Danielisová V, Gottlieb M, Némethová M, Kravčuková P, Domoráková I, et al. (2009) Bradykinin postconditioning protects pyramidal CA1 neurons against delayed neuronal death in rat hippocampus. Cell Mol Neurobiol 29: 871-878.
28. Xia CF, Smith RS Jr, Shen B, Yang ZR, Borlongan CV, et al. (2006) Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor. Hypertension 47: 752-761.
29. Kaplanski J, Pruneau D, Asa I, Artru AA, Azez A, et al. (2002) LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces brain edema and improves long-term neurological function recovery after closed head trauma in rats. J Neurotrauma 19: 953-964.
30. Zausinger S, Lumenta DB, Pruneau D, Schmid-Elsaesser R, Plesnila N, et al. (2002) Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia. Brain Res 950: 268-278.
31. Francel PC, (1992) Bradykinin and neuronal injury. J Neurotrauma 9 (Suppl 1): S27-45.
32. Kamiya T, Katayama Y, Kashiwagi F, Terashi A, (1993) The role of bradykinin in mediating ischemic brain edema in rats. Stroke pp. 571-576.
33. Gröger M, Lebesgue D, Pruneau D, Relton J, Kim SW, et al. (2005) Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25: 978-989.
34. Joseph K, Kaplan AP, (2005) Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol 86: 159-208.
35. Howl J, Payne SJ, (2003) Bradykinin receptors as a therapeutic target. Expert Opin Ther Targets 7: 277-285.
36. Austinat M, Braeuninger S, Pesquero JB, Brede M, Bader M, Stoll G, et al. (2009) Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema. Stroke 40: 285-293.
37. Regoli D, Rizzi A, Perron SI, Gobeil F jr, (2001) Classification of kinin receptors. Biol Chem 382: 31-35.
38. Neumann J, Gunzer M, Gutzeit HO, Ullrich O, Reymann KG, Dinkel K, (2006) Microglia provide neuroprotection after ischemia. FASEB J 20: 714-716.
39. Schurr A, Payne RS, Heine MF, Rigor BM, (1995) Hypoxia, excitotoxicity and neuroprotection in the hippocampal slice preparation. J Neurosci Methods 59: 129-138.